|
Index of reports
> Cases with Neurotoxicity (1)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Brevibloc (Esmolol) where reactions include neurotoxicity. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Brevibloc side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-22
Patient: male, weighing 2.0 kg (4.4 pounds)
Reactions: Neurotoxicity, Drug Interaction, Toxicity To Various Agents
Drug(s) suspected as cause:
Dopamine HCL IN 5% Dextrose
Indication: Positive Cardiac Inotropic Effect
Milrinone Lactate IN 5% Dextrose Injection IN Plastic Container
Indication: Cardiac Output Decreased
Brevibloc
Brevibloc
Brevibloc
Isoproterenol HCL
Indication: Heart Rate Decreased
Lidocaine
Indication: Ventricular Arrhythmia
Brevibloc
Indication: Ventricular Arrhythmia
Brevibloc
Other drugs received by patient possibly interacting with the suspect drug:
Phenytoin
Nexterone
Indication: Torsade DE Pointes
Nexterone
Lidocaine HCL
Indication: Ventricular Arrhythmia
Lidocaine HCL
Lidocaine HCL
Phenytoin
Indication: Ventricular Tachycardia
Other drugs received by patient: Calcium Gluconate; Magnesium; Albutein; Vecuronium Bromide; Potassium Chloride; Fentanyl
|
